Five emerging liability claim trends are reshaping the risk landscape, finds a report by Allianz Commercial.

The discovery of vast stores of lithium in the U.S. heralds business opportunities for insurers; not without risk however.

Product recalls surge across key industries in 2024, with over 580 million units affected through September alone, Sedgwick’s quarterly analysis reveals.

Heightened tensions over ESG are prompting many organizations to lower the volume on their public statements and disclosures.

Learn what happens when 3D-printed construction projects fail to deliver and risks start getting real in a brave new world at the CLM 2023 Construction Conference.

Food and drink recall and contamination can be detrimental to a business that does not have adequate coverage to handle this costly risk.

The use of autonomous vehicles is attractive to many, but where liability lies should an accident occur is still a murky issue.

The latest trends in the ongoing battle over liability in America’s opioid abuse epidemic.

Here’s what manufacturers should do to mitigate PFAS risks before the EPA standard is released.

“The Next Asbestos” they say, but where PFAS and asbestos differ is in the longevity and reach of these forever chemicals. Manufacturers must get ahead of the risk.

Is adequate risk transfer in the face of rapid technological change even possible?

Demand for construction and environmental professional liability products is expected to rise this year as construction activity rebounds from the impact of the COVID-19 pandemic.

The aviation industry is rebounding after COVID-19 but it may never look exactly like it did pre-pandemic.

A promising government contract for a manufacturer turns into a liability nightmare when its leadership team fails to adequately vet its supply chain.

With millions of people having now been vaccinated, health care facilities and their insurers are on the lookout for vaccination-related risk.

The details of a fatal crash highlight the limitations of artificial intelligence, and the complexity of determining fault when machines are in charge.

From mounting opioid litigation to the more recent Risperdal suit, J&J is in the hot seat, teaching other companies the value reputation can hold.

What happens when foreign powers start holding U.S. companies liable for gun deaths suffered by their citizens on U.S. soil? A whole new area and era of risk exposure.

With more than 2,000 lawsuits pending across the country, drug manufacturer Johnson & Johnson is in the legal hot seat.

Distributed ledger technology has the potential to improve supply chains worldwide and to minimize product recall losses. Now is the right time to prepare for widespread adoption.